Pediatric ALLNCT06249880
Pediatric Normative Markerless Movement Analysis
An observational study of Pediatric ALL and Adolescent, run by MultiCare Health System Research Institute at 1 site in United States.
Trial summary
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab. Read more about this study
- Who is it for?
- Ages 3 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Pediatric ALL, Adolescent
- What is being tested?
- Observation
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Mar 2024to Dec 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 25 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Subjects will be recruited from the regional community, including convenience sample of children. Subjects will be recruited by word of mouth, posted flyers, and advertised through the RML website and MB social media.
Who may be able to join
- Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion).
- Ambulate independently and without the use of assistive devices or orthoses.
- Willing and interested in participating.
Who cannot join
- Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
- Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
- Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
- History of premature birth.
- Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Mary Bridge Children's Therapy Unit - Research & Movement Lab
Puyallup, Washington, 98372
Brenna Brandsma, DPT, 253-697-5268, babrandsma@multicare.org
About this study
Official title: Pediatric Normative Markerless Movement Analysis Data Collection Project
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Read the detailed description
The objective of this project is to collect baseline data from a normative population of children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab. This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.
- Conditions
- Pediatric ALL, Adolescent
- Being tested
- Observation
- Keywords
- Motion Analysis, Kinetics, Kinematics
- Medical subject headings
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationOther
This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.
| Study group | Role | What they receive |
|---|---|---|
| Normative | 40 neurotypical pediatric subjects Receives: Other: Observation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Observation-based movement analyses
The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2024
- Study start1 Mar 2024
- Primary completionDec 2027 (estimated)
- Study completionDec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric ALLStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- MultiCare Health System Research Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Brenna Brandsma, MultiCare Health System Research Institute
- Investigators
- Brenna Brandsma, Principal investigator, Mary Bridge Chidlren's
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06249880
- Sponsor's protocol ID
- #2023/11/2
- Status last verified
- Mar 2026
- First submitted
- 24 Jan 2024
- Last updated
- 9 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pediatric Normative Markerless Movement Analysis Data Collection Project
- ClinicalTrials.gov ID
- NCT06249880
- Acronym / sponsor ID
- #2023/11/2
- Conditions
- Pediatric ALL, Adolescent
- Keywords
- Motion Analysis, Kinetics, Kinematics
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- MultiCare Health System Research InstituteUniversity, hospital or other
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2028 (estimated)
- First posted
- 8 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Detailed description
The objective of this project is to collect baseline data from a normative population of children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab. This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Normative | – | Other: Observation40 neurotypical pediatric subjects |
Who may qualify
- Ages
- 3 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Subjects will be recruited from the regional community, including convenience sample of children. Subjects will be recruited by word of mouth, posted flyers, and advertised through the RML website and MB social media.
Key inclusion criteria (3 listed)
- Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion).
- Ambulate independently and without the use of assistive devices or orthoses.
- Willing and interested in participating.
Key exclusion criteria (5 listed)
- Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
- Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
- Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
- History of premature birth.
- Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ObservationThis project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait. | Other | Normative |
Primary outcome
Observation-based movement analyses
Time frame: Baseline
The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2026.
Related trials for Pediatric ALL
Recruiting
Hospital Based Continuous Patient Monitoring System
Trauma, Appendectomy
Not yet recruitingPhase 1/2
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Recruiting
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Melanoma Stage III, B-cell Non Hodgkin Lymphoma
RecruitingObservational study
CAYA Cancer Prospective Cohort Study
Cancer, Pediatric Cancer
RecruitingObservational study
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Pediatric ALL, Cardiac Defect
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Brenna Brandsma principal investigator
Mary Bridge Chidlren's
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pediatric ALL and Adolescent, run by MultiCare Health System Research Institute at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Brenna Brandsma, PT, DPT, PCS (253-697-5268, brenna.brandsma@multicare.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Observation-based movement analyses (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026; AzTrials last refreshed its copy on 30 Oct 2026.